Sign in
Not yet recruitingNo phase

Oxygen Test During Liver Transplant to Predict Early Graft Problems

Studies whether a blood-flow test can predict early graft dysfunction in liver transplant patients.

Key facts

Who runs it
Ippokrateio General Hospital of Thessaloniki
Where
Greece1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Intraoperative Assessment of Microcirculatory Function Using Vascular Occlusion Test During Liver Transplantation
Status
Not yet recruiting
People taking part
50 people, planned
Started
Jun 2026
Expected to end
Jun 2027
Type of study
Observational
Record updated
1 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are about to have a liver transplant. During surgery, a sensor on the arm will measure how well blood reaches small vessels.

Age
18 years or older
Sex
All sexes can join.
Disease stage
People scheduled for a liver transplant (orthotopic liver transplantation).

Main reasons for not taking part

  • Younger than 18 years
  • Refusing or unable to give written consent
  • Emergency liver transplant with no time to enrol
  • The arm test (Vascular Occlusion Test) or NIRS measurements cannot be done or are not reliable
  • Severe disease of the blood vessels in the limbs, or arm problems that get in the way of the measurements

This trial only enrols participants who have had an organ transplant. The registry sentence this rests on: Patients scheduled to undergo orthotopic liver transplantation

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adult patients aged 18 years or older
  • Patients scheduled to undergo orthotopic liver transplantation
  • Ability to obtain intraoperative Near-Infrared Spectroscopy measurements
  • Written informed consent obtained before enrollment

Who cannot take part

  • Emergency liver transplantation without sufficient time for enrollment
  • Severe peripheral vascular disease or local upper-limb conditions interfering with monitoring
  • Age younger than 18 years
  • Refusal or inability to provide informed consent
  • Inability to perform the Vascular Occlusion Test or obtain reliable NIRS measurements

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Early allograft dysfunction (EAD) remains one of the most important complications following orthotopic liver transplantation (OLT). Currently, there is no established intraoperative biomarker that reliably predicts graft dysfunction at an early stage. Near-infrared spectroscopy (NIRS) combined with the vascular occlusion test (VOT) is a non-invasive method for assessing tissue oxygenation and microcirculatory reserve. This prospective observational study aims to investigate whether VOT-derived parameters, including desaturation slope, recovery slope and post-ischemic hyperemic area under the curve (AUC-H), can predict EAD in liver transplant recipients. Measurements will be performed at four predefined intraoperative timepoints: after induction of anesthesia, during the anhepatic phase, during the neohepatic phase and at the end of surgery. The primary outcome is the occurrence of EAD according to Olthoff criteria.

The group in the trial

  • Adult Liver Transplant Recipients Undergoing Intraoperative VOT/NIRS Monitoring

    Adult patients undergoing orthotopic liver transplantation will be enrolled in this observational cohort. During surgery, they will undergo standardized Vascular Occlusion Tests using Near-Infrared Spectroscopy to assess peripheral tissue oxygen saturation and microcirculatory reactivity. Measurements will be performed at predefined intraoperative timepoints, including baseline, anhepatic, neohepatic and final phases. Reoxygenation slope, hyperemic area under the curve and related parameters will be analyzed for their association with early allograft dysfunction and postoperative outcomes.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Predictive Value of the Vascular Occlusion Test During Orthotopic Liver Transplantation for the Development of Early Allograft Dysfunction
Plain-language title
Oxygen Test During Liver Transplant to Predict Early Graft ProblemsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
1 July 2026